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Some Pharmacologic and Toxicologic
Effects of Di 2-ethylhexyl Phthalate
(DEHP) and Other Plasticizers*
by Robert J.Rubin t and Rudolph J. Jaeger**
With the recent demonstration of the
migration of phthalate ester plasticizers from
vinyl plastic biomedical devices (1-4), its
identification in human and animal tissues
(5, 6), and evidence for its ubiquitous
distribution in the environment (7, 8),tt it
has become necessary to reevaluate the
toxicologic potential of this class of chemi-
cal compounds. Di-2-ethylhexyl phthalate
(DEHP), as an example of the most widely
used of the phthalate esters, deserves par-
ticular emphasis. In general, the phthalate
esters have been reported to have a low
order of acute toxicity (9-11). For
example, of eight different phthalate esters
examined in one study, the intraperitoneal
LD50 dose in mice ranged from 1.5 to 14.2
g/kg. In rats, the intraperitoneal LD50 of
DEHP has been reported by several investiga-
tors to range from 2 to 31 g/kg. One report
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by Hodge in 1943 (9) indicated that a single
intraperitoneal dose of 128 g/kg of DEHP
produced death in only 5% of a group of
treated mice. Other studies on the oral
administration of DEHP indicated an LD50
of approximately 30 g/kg in rats and rabbits
given a single oral dose. Ninety-day and
2-year feeding studies in rats and 1-year
feeding studies in guinea pigs and dogs
likewise indicated a low order of toxicity for
DEHP. These data have resulted in the Food
and Drug Administration approving DEHP
for use in plastic wrapping for food intended
for human consumption (12).
The major shortcoming of the available
toxicologic data is that they deal primarily
with gross, overt effects, i.e., morbidity,
mortality, changes in body and organ
weights, and histologic changes. They do not
take into account more subtle toxicologic
effects. [Examples of the subtle toxic effects
of vinyl plastics additives have been given in
the literature (13-16).] This paper presents
such subtle effects observed in our labora-
tory.
Results
Effect of DEHP on Response to Drugs
It has been well documented that xeno-
biotics (drugs, environmental chemicals,
etc.) are metabolized in the liver and that
January 1973 53such metabolism determines to a large
extent the duration of response to that
chemical in the body. Furthermore, it has
been shown that a wide variety of chemicals
are able to alter this metabolic system (17).
Experiments were undertaken to deter-
mine if acute treatment with phthalate esters
would alter the response of rats and mice to
a commonly employed test drug, hexo-
barbital. The duration of the anesthetic
effect of the barbiturate, referred to here as
"sleeping time," was determined. Male mice,
of body weights in the 20-22g range, were
treated with either 250 mg/kg or 500 mg/kg
of butylglycolyl butyl phthalate (BGBP) or
di-2-ethylhexyl phthalate (DEHP). The
phthalates were prepared as emulsions in 3%
acacia in physiological saline as the vehicle.
Control mice received appropriate volumes
of the acacia vehicle. Thirty minutes after
administration of the phthalate or vehicle,
hexobarbital was administered intra-
peritoneally at a dose of 60 mg/kg. The
duration of barbiturate-induced sleep was
taken from the time of injection of hexobar-
bital to the time the animal regained his
righting reflex. The results are shown in
Figure 1. It can be seen that both doses of
DEHP produce a significant increase in sleep-
ing time over control values, the higher dose
producing approximately a doubling in sleep
time. BGBP was correspondingly less effec-
tive. The lower dose produced no significant
effect, but the higher dose showed a signifi-
cant prolongation, though less than with the
same dose of DEHP.
A comparable effect of DEHP was seen in
rats. The results are shown in Figure 2. In
these experiments, male rats weighing
200-250g, were given DEHP intraperitoneally
at a dose of 500 mg/kg as an emulsion
in acacia. As with the mice, hexobarbital
at a dose of 250 mg/kg was given 30 min
after administration of the phthalate or
vehicle. It can readily be seen that DEHP,
at the dose used, causes only a slight though
significant increase in hexobarbital sleeping
time. Shown along the bottom portion of
the figure are the blood levels of hexobar-
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FIGURE 1. Effect of BGBP and DEHP on hexo-
barbital sleeping time in mice. The asterik indi-
cates responses that are significantly different (P
< 0.05) from vehicle-injected controls. NS= not
significant (P > 0.05). The numbers in paren-
theses are the number of animals tested per
group. Brackets represent ± 1 standard error.
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FIGURE 2. Effect of DEHP and 2-ethylhexanol
(2-EH) on hexobarbital sleeping time in rats.
Asteriks, brackets, and numbers in parentheses
are the same as in Figure 1.
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ately upon the animal awakening. It can be
seen that, although there is a prolongation
of pharmacologic response to hexobarbital,
this effect is not produced by an increased
sensitivity of the central nervous system to
the depressant effects of the barbiturate.
This is indicated by the fact that the rats
treated with DEHP awoke when the concen-
tration of hexobarbital in the blood reached
the same level at which the controls awoke.
Also shown in Figure 2 are the results
obtained when the rats were pretreated with
an equimolar concentration of 2-ethyl-
hexanol (2-EH), a known anesthetic that
represents a possible metabolite of DEHP.
The results seen with 2-EH are consistent
with the possibility that the de-esterified
product of DEHP might account for the
ability of the ester to prolong barbiturate
anesthesia. Although there is a trend with
2-EH for an increased degree of sensitivity
of the CNS to hexobarbital, the lowered
blood level of the barbituate is not signifi-
cantly different from that seen in the
controls.
The ability of DEHP to prolong hexobar-
bital sleeping time. in vivo without any
significant alteration in the waking blood
levels of the barbiturate suggests that the
effect is related to a decreased rate of
disappearance of the test drug from the
blood. Since a major route for the elimina-
tion of this drug from the body is via
hepatic metabolism, the effect of DEHP on
the rate of hexobarbital metabolism in the
isolated, perfused rat liver was studied. The
results are seen in Figure 3. DEHP was
added to the perfusate at an initial level of
70 ,g/ml. This level was established prior to
installation of the isolated liver. The DEHP-
containing perfusate was then allowed to
circulate through the liver for 2 hr, after
which time hexobarbital was added to the
main perfusate reservoir. The level of hexo-
barbital in the reservoir was then determined
over the next 30 min of perfusion. It can be
seen from the figurethatthe barbiturate disap-
peared logarithmically in this preparation
and that the rate of disappearance was not
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FIGURE 3. Rate of disappearance of hexobarbital
in the isolated rat liver perfusion system.
significantly altered by DEHP. However, at
each time point the hexobarbital level in the
perfusate was significantly lower in the
DEHP-treated system. Presumably, this is
related to a more rapid initial distribution of
the barbiturate into the liver followed by no
significant alteration in its rate of metab-
olism. This experiment thus rules out an
effect of DEHP on the rate of hepatic
metabolism as an explanation for its ability
to prolong hexobarbital sleeping time. The
data, on the other hand, suggest the possibil-
ity for an effect on the distribution of the
drug into various organs. Such barbiturate
distribution measurements have not yet been
made. Though the exact mechanism is not
known, it is clear that BGBP and DEHP can
alter the pharmacologic response to a barbi-
turate.
Behavioral Effects
Behavioral effects were evaluated in two
different systems: (a) self-stimulation of the
hypothalamic "pleasure center" and (b)
spontaneous running in a metered activity
wheel. In the former system, permanent
electrodes were stereotaxically implanted in
the hypothalamic pleasure center of the rat's
brain. Following recovery from the surgical
procedure, the rat was taught that by pres-
sing a bar in a test cage, he would be able to
January 1973 55activate the electrodes and thus receive a
"pleasureable" stimulus. After a short period
of training, each rat displayed a rather
characteristic rate of bar-pressing activity
during a daily 1-hr test period. The effect of
an intraperitoneal dose of 500 mg DEHP/kg
on rats in this test system is shown in Figure
4. The DEHP was administered 2 hr before
the rats were placed in the test situation.
The data are presented as the mean per cent
of the control rate of bar pressing. It can
readily be seen that the intraperitoneal ad-
ministration of the acacia vehicle slightly,
but nonsignificantly, decreased the bar-
pressing rate. DEHP, on the other hand,
depressed the rate to 30% of control.
Figure 5 shows the results of the study on
the free-running activity of the rats. Animals
were maintained in individual cages having
access to a freely rotating drum on which
was mounted a mechanical metering device
for recording the numbers of revolutions.
DEHP (500 mg/kg) or vehicle was admin-
istered at 12 noon, and the running activity
was monitored during the following 24-hr
period. It can be seen that injection of the
vehicle alone significantly altered this behav-
ioral activity from control levels. However, it
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FIGURE 5. Effect of DEHP on the 24-hr free-
running activity of rats. Data expressed as in
Figure 4.
is clear from the data that DEHP virtually
eliminated all running activity during the
subsequent 24-hr period.
In spite of these behavioral deficits
elicited by DEHP, it is important to note
that animals appeared not to be in a
narcotized or anesthesized state. They ap-
peared to be reasonably alert to external
stimuli.
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FIGURE 4. Effect of DEHP on hypothalamic self-
stimulation in rats. The cross-hatched area
indicates the control rate ± 1 standard error and
is expressed as 100. The experimental data is
expressed as the mean of the per cent change
from control observed for each animal.
Effect on Recticuloendothelial Function
Unpublished studies (2) have indicated the
accumulation of DEHP in those organs hav-
ing a high degree of reticuloendothelial
function, i.e., liver, spleen, and lungs. For
this reason, experiments were undertaken to
evaluate the effect of DEHP on reticulo-
endothelial activity in the intact animal. The
system chosen for study was the clearance
of colloidal carbon particles from the blood
of intact rats. In these experiments rats were
anesthesized with pentobarbital and given an
intravenous dose of colloidal carbon (40
mg/kg). At 2-min intervals blood samples
were drawn from the tail vein and assayed
for colloidal carbon. The results are shown
in Figure 6, where it can be seen that in
vehicle-treated controls the colloidal carbon
clearance is logarithmic with a half-time of
approximately 4 min. Intravenous admini-
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FIGURE 6. Effect of acute and subacute intra-
venous doses of DEHP on in vivo reticulo-
endothelial function in rats. Each data point is
the mean ± 1 standard error for the number of
animals indicated in parentheses.
stration of a single dose of 500 mg of
DEHP/kg 24 hr prior to the test dose of
carbon resulted in a significant depression in
the clearance rate. On the other hand, four
injections of 125 mg of DEHP/kg each,
given on alternate days with the carbon
clearance test given 24 hr after the last of
the four doses, resulted in a significant
increase in the rate of carbon clearance.
Thus, depending on the schedule of admini-
stration, DEHP can either depress or stimu-
late reticuloendothelial function.
Relationship of DEHP to Microaggregation
of Platelets in Stored Blood
In addition to any direct toxicologic
effects of DEHP on the intact animal is the
problem of evaluating the effect of this
compound (or class of compounds) on the
quality of blood stored in vinyl plastic bags
for transfusion. One of the major drawbacks
of stored blood is the progressive accumula-
tion of microembolic aggregates which carry
a threat of occluding the capillary beds of
the transfusion recipient. Swank (18) has
demonstrated that these aggregates consist of
clumps of platelets which form because of
an increasing degree of platelet adhesiveness.
Based on unpublished observations from this
laboratory on the high affinity of stored
platelets for DEHP (2), it became of interest
to determine the relationship between the
DEHP content of stored blood and the
extent of microaggregate formation.
A direct measure of microaggregate forma-
tion is available by measurement of the
pressure generated across a filtration screen
of given porosity when blood is pumped
across that screen at a constant flow. The
pressure, referred to as screen filtration
pressure (SFP), measures the resistance to
flow, and as such is a measure of the
occlusion of the pores and the adhesiveness
that the occluding particles have for one
another. The procedure is essentially that
described by Swank (19).
Dog blood was stored in commercial vinyl
plastic storage bags for periods of time up to
21 days. At varying periods of time, aliquots
were removed aseptically, and assayed for
screen filtration pressure and DEHP content.
The correlation of these two parameters are
shown in Figure 7. A highly significant
correlation coefficient r of + 0.84 was found
between the degree of microaggregation as
measured by screen filtration pressure and
the content of DEHP. It should be empha-
sized, however, that a correlation does not
imply a cause and effect relationship. These
results, indicating a significantly high degree
of correlation, merely point out the need for
further direct studies of the effect of DEHP
on platelet aggregation.
Effect on Embryonic Heart Cells Maintained
in Tissue Culture
In experiments on beating chick embryo
heart cells maintained in tissue culture,
performed in collaboration with Dr. Robert
DeHaan of the Carnegie Institute of
Washington, it was observed (Table I) that
DEHP at levels of 4 pg/ml in the tissue
culture media resulted in the complete cessa-
tion of function. Within 24 hr, some
97-98% of the cells were dead and under-
going autolysis. Another type of plasticizer,
di-2-ethylhexyl adipate (DEHA) at a level of
January 1973 57Table 1. Effect ofplasticizers on beating chick heart cells maintained in
tissue culture.
Concentration in Beating heart cells Viable heart cells
culture medium, at 30 min, % at 24 hr, %
Plasticizer ,ug/ml ofcontrol cultures of control cultures
DEHP 4.0 2 - 3 2 - 3
DEHA 1.5 50 100
x
150-
PVC X
r r- 0.84
100_
Screen
filtration
pressure X
mm.Hg.
50_ x
0 1 2 3 4 5
DEHP content mg./lOOmI.
FIGURE 7. Correlation of DEHP content of dog
blood stored in PVC plastic bags and the pres-
ence of microaggregates as measured by screen
filtration pressure.
1.5 mg/ml reduced the number of beating
cells to 50% of control levels, but essentially
all the cells were viable after 24 hr.
Conclusions
Previous published data on the toxicology
of the phthalate esters (including DEHP)
have indicated a low order of toxicity.
However, the results presented here indicate
that, under the appropriate conditions,
DEHP can be demonstrated to have signifi-
cant effects on a variety of biological sys-
tems. These effects would not be observed,
for the most part, in the classical toxicologic
evaluations upon which the relative safety of
plasticizers have been previously based.
Of particular interest is the sensitivity of
embryonic heart cells to DEHP. A level of 4
,ug/ml in the culture media is lethal to
97-98% of these cells. It should be pointed
that this level of DEHP is one that is
reached in human blood stored in vinyl
plastic bags after a period of 1-2 days of
storage (2, 5). Also, of concern in this regard
is the recent report of Nazir et al. (6) of
the localization of DEHP in beef heart
mitochondria.
In general, it is felt that the results
presented in this paper warrant a further
detailed evaluation of the potential toxicity
of those additives such as plasticizers which
have a high tendency for migration from the
finished product. These continuing evalua-
tions will be necessary until technology
yields a usable vinyl plastic subsitute from
which migration of additives, under condi-
tions of use, is negligible.
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